Table S2 from RGN6024 Is a Brain-Penetrant, Small-Molecule Tubulin Destabilizer for the Treatment of Glioblastoma

Key Points

• RGN6024 demonstrates significant effects on glioblastoma cell line viability.
• The drug acts as a small-molecule tubulin destabilizer, impacting cancer cell growth.
• Experimental tests reveal its potential as a brain-penetrant therapy for aggressive tumors.
• This research may influence future strategies in glioblastoma treatment by targeting tubulin disruption.